Free Trial

Laboratory Co. of America (LH) Stock Price, News & Analysis

$223.91
-3.43 (-1.51%)
(As of 09/6/2024 ET)
Today's Range
$223.81
$229.70
50-Day Range
$199.35
$236.00
52-Week Range
$191.97
$238.46
Volume
488,233 shs
Average Volume
688,116 shs
Market Capitalization
$18.88 billion
P/E Ratio
45.05
Dividend Yield
1.29%
Price Target
$250.82

Laboratory Co. of America MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
12.0% Upside
$250.82 Price Target
Short Interest
Healthy
2.00% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
1.28mentions of Laboratory Co. of America in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$6.72 M Sold Last Quarter
Proj. Earnings Growth
8.18%
From $14.67 to $15.87 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.97 out of 5 stars

Medical Sector

3rd out of 910 stocks

Medical Laboratories Industry

1st out of 18 stocks

LH stock logo

About Laboratory Co. of America Stock (NYSE:LH)

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

LH Stock Price History

LH Stock News Headlines

Say Goodbye to the US Dollar
The warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late...
Say Goodbye to the US Dollar
The warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late...
Labcorp Holdings EVP Trades Company's Stock
Laboratory Corp of America Holdings (LAB.HA)
See More Headlines
Receive LH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Laboratory Co. of America and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 6/12 Dividend
5/24/2024
Dividend Payable
6/12/2024
Last Earnings
8/01/2024
Ex-Dividend for 9/13 Dividend
8/29/2024
Today
9/07/2024
Dividend Payable
9/13/2024
Next Earnings (Estimated)
10/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
Health Care Services
CUSIP
50540R40
Employees
67,000
Year Founded
1995

Price Target and Rating

Average Stock Price Target
$250.82
High Stock Price Target
$277.00
Low Stock Price Target
$215.00
Potential Upside/Downside
+12.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
12 Analysts

Profitability

Net Income
$418 million
Pretax Margin
5.26%

Debt

Sales & Book Value

Annual Sales
$12.49 billion
Cash Flow
$19.80 per share
Book Value
$95.35 per share

Miscellaneous

Free Float
83,583,000
Market Cap
$18.88 billion
Optionable
Optionable
Beta
1.06

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives


LH Stock Analysis - Frequently Asked Questions

How have LH shares performed this year?

Laboratory Co. of America's stock was trading at $227.29 on January 1st, 2024. Since then, LH shares have decreased by 1.5% and is now trading at $223.91.
View the best growth stocks for 2024 here
.

How were Laboratory Co. of America's earnings last quarter?

Laboratory Co. of America Holdings (NYSE:LH) announced its quarterly earnings data on Thursday, August, 1st. The medical research company reported $3.94 earnings per share for the quarter, beating the consensus estimate of $3.78 by $0.16. The business's quarterly revenue was up 6.2% compared to the same quarter last year.
Read the conference call transcript
.

What is Adam Schechter's approval rating as Laboratory Co. of America's CEO?

143 employees have rated Laboratory Co. of America Chief Executive Officer Adam Schechter on Glassdoor.com. Adam Schechter has an approval rating of 73% among the company's employees.

Does Laboratory Co. of America have any subsidiaries?

Laboratory Co. of America subsidiaries include Clinical Outreach Laboratory Services, Personal Genome Diagnostics Inc., Toxikon Corporation, Myriad Autoimmune’s Vectra Testing Business, Ovia Health, Visiun, Envigo's nonclinical contract research services business, and more.

Who are Laboratory Co. of America's major shareholders?

Laboratory Co. of America's top institutional shareholders include Diamond Hill Capital Management Inc. (2.31%), Bank of New York Mellon Corp (1.91%), Allspring Global Investments Holdings LLC (1.90%) and Dimensional Fund Advisors LP (1.68%). Insiders that own company stock include Glenn A Eisenberg, Lance Berberian, Kerrii B Anderson, Brian J Caveney, Paul R Kirchgraber, Mark S Schroeder, Amy B Summy, Der Vaart Sandra D Van, Jonathan P Divincenzo, Peter J Wilkinson, Peter M Neupert, R Sanders Williams and Dwight Gary Gilliland.
View institutional ownership trends
.

How do I buy shares of Laboratory Co. of America?

Shares of LH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Laboratory Co. of America own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Laboratory Co. of America investors own include Gilead Sciences (GILD), Micron Technology (MU), Intel (INTC), Pfizer (PFE), Johnson & Johnson (JNJ), NVIDIA (NVDA) and Abbott Laboratories (abt).

This page (NYSE:LH) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners